BIRMINGHAM, UK – 11 December 2025 – MirZyme Therapeutics, a UK-based, clinical stage biotechnology company developing diagnostic and therapeutic solutions for preeclampsia, has been named the winner of the 2025 Institute of Physics (IOP) Business Start-Up Award. The award recognises companies applying physics and biophysics to deliver commercially scalable technologies with significant real-world impact. The IOP Business Awards are the Institute’s highest industry honour, awa

Every life saved begins with early detection. MPREG® empowers timely intervention—because no baby should be lost to preeclampsia. ...

MirZyme announced today that it was selected as a spoke for the Investor Catalyst Hub, a regional hub of ARPANET-H, a nationwide health...

The MirZyme Therapeutics team are delighted to announce that we have been granted a new US patent to predict and prevent pregnancy...